EquiTech Corporation


November 18, 2002	Re-priced Private Placement Offering
September 25, 2002	EquiTech Corporation Announces Patent Pending Enhanced Absorption Technology and Pharmaceutical Products
July 29, 2002	EquiTech announces $150,000 Technology Commercialization Funding from Alberta Heritage Foundation
July 9, 2002	Elizabeth Watts appointed EquiTech’s Director of Regulatory Affairs and Clinical Operations
July 3, 2002	EquiTech announces granting of options to WBC Consulting (2000) Inc. and Foundation Equity Corp.
June 18, 2002	EquiTech announces amendment to terms of private placement
June 10, 2002	Dr. Abraham Sunshine appointed Chairman of EquiTech’s Scientific Advisory Board
June 7, 2002	EquiTech announces granting of options to Analgesic Development Ltd. and to Dr. Abraham Sunshine
May 31, 2002	EquiTech announces non-brokered private placement of up to $2,000,000
May 9, 2002	EquiTech announces granting of options
April 24, 2002	EquiTech acquires Zagros Pharma Ltd. at Annual and Special Meeting of Shareholders; EquiTech also acquires new analgesic technologies
Feb 1, 2002	EquiTech announces granting of options in exchange for interest in Zagros technology